Linda Cecilia Honet, MD

One of the beauties behind CoolSculpting is its lack of downtime. Although you may experience slight discomfort after treatment,  the discomfort is nothing that will take you off your feet. Most patients who get treated with the CoolSculpt resume their regular activities the same day.

CoolSculpting recommends that each treatment cycle is completed for the full time for optimal results.  The cycle time of 25 minutes is not enough time for an adequate treatment. Any use of the CoolSculpt not recommend by CoolSculpting, is considered off label and does not have any supporting data, therefore a shorter treatment time is not suggested.

CoolSculpting uses freezing technology to target unwanted areas of fat and permanently destroy fat cells. There is a CoolSculpt applicator that is ideal for patients who complain of issues with fat on the outer thigh, that forms saddlebags. The results of the treatment are wonderful, patients are highly satisfied. It is ideal if you contact a CoolSculpting office near you to request a consultation with a physical exam to determine what is best for you.

The SilkPeel Dermalinfusion provides different solutions for all skintypes. SilkPeel uses a diamond tip handpiece exfoliating damaged skin cells, and evenly abrading the top layer of the skin. All while delivering a condition-specific topical being infused into the skin leaving you with even-toned, brighter skin. Whether you are trying to target acne, dark spots, redness, or dry skin, SilkPeel can be personalized to your needs. With no downtime, patients find SilkPeel Dermalinfusion more effective than most chemical peels.

As a great Vitamin A derivative, Tazorac can be used nightly or a few times a week.  Tazorac can be used as a first layer after cleansing nightly, it will help with fine lines, wrinkles, and prevention of sun damage. If you find yourself being too dry, try mixing your Tazorac cream with a moisturizer as your first layer after cleansing. It will help with tightening and minimizing pores as well.